PreprintCited by 1Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and TherapyGenomics and Rare Diseases

Comprehensive Variant Effect Map of Parkin-Mediated Mitophagy in Parkinson’s Disease

Open access
Sigmarsdóttir, Erna Sól, Voutsinos, Vasileios, Johansson, Kristoffer Enøe, Henrichs, Isa Kristin, Buhrmann, Alissa, Lindorff-Larsen, Kresten, Hartmann-Petersen, Rasmus·2026·bioRxiv (Cold Spring Harbor Laboratory)

Abstract

The development of Parkinson’s disease (PD) has a substantial genetic basis. Variants in the PRKN gene account for roughly half of autosomal-recessive PD cases, yet most variants remain classified as variants of uncertain significance. PRKN encodes the E3 ubiquitin-protein ligase, Parkin, that plays a key role in mitochondrial quality control by initiating mitophagy. In this work, we introduce a multiplexed mitophagy assay and measure the activity of more than 99% of all possible single–amino acid substitution and nonsense variants of Parkin. We also demonstrate that misfolded, rapidly degraded variants autonomously trigger Parkin-independent mitophagy. The obtained activity landscape closely reflects known structural and functional aspects of Parkin while revealing new insights into specific functional effects across the protein. This dataset near-perfectly distinguishes pathogenic from benign variants and surpasses both computational predictors and abundance-based metrics in pathogenicity assessment. Finally, the data pinpoint hypomorphic variants that could be amenable to rescue in future personalized therapeutic approaches for PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.64898/2026.02.09.704749

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two independent MAVEs of Parkin using different cellular systems and assay designs showed strong agreement (R = 0.77) and high diagnostic performance (ROC AUC 0.92 and 0.94), despite differences in library design, functional readout, and model system.

    “Two independent MAVEs of Parkin using different cellular systems and assay designs showed strong agreement (R = 0.77) and high diagnostic performance (ROC AUC 0.92 and 0.94), despite differences in library design, functional readout, and model system (101, 102).”

    From Massively parallel functional genomic assays in endocrinology: from promise to delivery (2026) · cites this paper as [101]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sigmarsdóttir, E. S., Voutsinos, V., Johansson, K. E., Henrichs, I. K., Buhrmann, A., Lindorff-Larsen, K., & Hartmann-Petersen, R.
Affiliations
  • University of Copenhagen (DK)
  • Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, 2200N Copenhagen, Denmark
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2026-02-09
OpenAlex
W7128537600
Cited by
1
References
3
Citations by year
2026: 1
Type
posted content
Language
en
Open access
Locations
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
Funders
  • Novo Nordisk Foundation (PRISM, NNF18OC0033950)
  • Parkinsonforeningen (A2456)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
Parkinson's disease, Parkin, mitophagy, mitochondrial quality control, E3 ubiquitin ligase, single amino acid substitution, nonsense mutation, variant pathogenicity assessment, variant effect prediction, hypomorphic variants, protein misfolding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review